Qol Holdings Co., Ltd. (3034) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Qol Holdings Co., Ltd. (3034:JPX), powered by AI.

Current Price
¥1,874
P/E Ratio
13.6
Market Cap
70.1B
Sector
Healthcare
What is the Qol Holdings Co., Ltd. stock price forecast?

Qol Holdings Co., Ltd. is currently trading at ¥1,874. View real-time AI analysis on Alpha Lenz.

What is Qol Holdings Co., Ltd. insider trading activity?

View the latest insider trading data for Qol Holdings Co., Ltd. on Alpha Lenz.

What is Qol Holdings Co., Ltd.'s P/E ratio?

Qol Holdings Co., Ltd.'s P/E ratio is 13.6.

Qol Holdings Co., Ltd.

JPX · 3034
¥1,874+12(+0.64%)Market closedJPX regular session 09:00–15:00 JST
Ask about Qol Holdings Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Qol Holdings Co., Ltd. trades at a P/E of 13.6 (undervalued) with solid ROE of 9.4%. 3Y revenue CAGR of 16.7% highlights clear growth momentum.

Ask for details

Company Overview

Qol Holdings Co., Ltd. operates within the healthcare sector, primarily focusing on the pharmaceutical distribution industry in Japan. The company's core function involves providing drug dispensing and pharmacy management services, aiming to enhance convenience and accessibility of medicines to consumers. With an extensive network of pharmacies, Qol Holdings facilitates the efficient distribution of clinical drugs, over-the-counter medications, and health-related products. Additionally, the company engages in contract research and research and development services, fostering industry innovation. Qol Holdings significantly impacts the healthcare industry by integrating advanced technology solutions to streamline pharmacy operations and improve customer service. Its importance in the market stems from its commitment to delivering high-quality healthcare services and its role in supporting Japan's healthcare infrastructure through wider access to pharmaceuticals and personalized patient care initiatives. This not only enhances public health outcomes but also positions Qol Holdings as a key player in the pharmaceutical supply chain in Japan.

SectorHealthcare
IndustryPharmaceutical Retailers
Employees6,254

Company Statistics

FY 2025

Profile

¥70,149,693,116Market Cap
¥263,972,000,000Revenue
0.00Shares Out
6,254Employees

Margins

14.80%Gross
8.48%EBITDA
5.10%Operating
4.86%Pre-Tax
2.83%Net

Valuation

13.58P/E
1.23P/B
0.27EV/Sales
4.00EV/EBITDA
-7.52P/FCF

Growth (CAGR)

16.67%Rev 3Yr
9.80%Rev 5Yr
10.96%Op Inc 3Yr
11.73%Op Inc 5Yr
10.81%Net Inc 3Yr
11.86%Net Inc 5Yr

Returns

5.39%ROA
9.40%ROE
9.42%ROIC

Financial Health

¥26,727,000,000Cash & Cash Equivalents
¥70,806,000,000Net Debt
156.97%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Qol Holdings Co., Ltd. (ticker: 3034) is a company listed on JPX in the Healthcare sector (Pharmaceutical Retailers). It has approximately 6,254 employees. Market cap is $70.1B.

The current price is 1,874 with a P/E ratio of 13.58x and P/B of 1.23x.

ROE is 9.40% and operating margin is 5.10%. Annual revenue is $264.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Qol Holdings Co., Ltd. (3034) Stock Forecast 2026 ¥1,874 — Price, Financials & Analyst Targets | Alpha Lenz